HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients

HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients

To evaluate whether on-treatment HBV-DNA level could predict the treatment response to entecavir in hepatitis B e antigen (HBe)-positive chronic hepatitis B (CHB) patients. Methods: A total of 68 treatment-naïve HBeAg-positive patients (75% male, mean age at 46.6 ± 11.9 years) receiving at least 2 y...

Full description

Bibliographic Details
Main Authors: Cheng-Yuan Peng, Tsung-Cheng Hsieh, Tsai-Yuan Hsieh, Kuo-Chih Tseng, Chih-Lin Lin, Tung-Hung Su, Tai-Chung Tseng, Hans Hsienhong Lin, Chia-Chi Wang, Jia-Horng Kao
Format: Article
Language:English
Published: Elsevier 2015-04-01
Series:Journal of the Formosan Medical Association
Subjects:
chronic hepatitis B
complete virological response
entecavir
hepatitis B e antigen
HBeAg loss
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664613003963

Internet

http://www.sciencedirect.com/science/article/pii/S0929664613003963

Similar Items